Albion Sues TriGen Over Iron Supplement Patent

Law360, New York (September 28, 2009, 2:55 PM EDT) -- TriGen Laboratories Inc. has been accused by rival pharmaceutical company Albion Laboratories Inc. of infringing a mineral supplement patent and creating a defective product that by association has sullied Albion's reputation in the sphere of mineral chelates.

In a suit filed in the U.S. District Court for the District of Utah on Friday, Albion and Breckenridge Pharmaceutical Inc. — Albion's licensed generics distributor — allege that TriGen has introduced several products that it has represented to be equivalents of Albion and Breckenridge iron absorption supplements without...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.